← FDA DRUG APPROVALS

FDA ANDA · ANDA062479

DOXYCYCLINE HYCLATE

Sponsor: RANBAXY

APPLICATION
ANDA062479
TYPE
ANDA
ORIGINAL APPROVAL
1983-12-23
LATEST ACTION
1993-06-01
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

DOXYCYCLINE HYCLATEDiscontinued
DOXYCYCLINE HYCLATE EQ 50MG BASE · CAPSULE · ORAL
DOXYCYCLINE HYCLATEDiscontinued
DOXYCYCLINE HYCLATE EQ 100MG BASE · CAPSULE · ORAL

Approval history

1993-06-01Labeling · Supplement 15AP
1993-02-19Labeling · Supplement 14AP
1983-12-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →